Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-11-29

Clinical Trial Update: Sanchitongtshu Plus Asprine for Minor Ischemic Stroke or Transient Ischemic Attack: A Randomized Double-blind Study [NA]

View source ↗

Summary

A randomized, double-blind trial evaluating Sanchitongtshu Plus with aspirin for patients with minor ischemic stroke or transient ischemic attack; the ClinicalT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Asprine (Aspirin)
  • Sanchitongtshu Plus

Snippet

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Stroke, Acute, Ischemic Attack, Transient | NA | Status: UNKNOWN